NVIDIA BioNeMo Framework Accelerates AI Drug Discovery

NVIDIA BioNeMo Framework Accelerates AI Drug Discovery

What You Should Know:  – NVIDIA announced widespread adoption of its open-source BioNeMo™ Framework by pharmaceutical companies, techbio innovators, and AI researchers to accelerate drug discovery and molecule design.  – The… Article Source https://hitconsultant.net/2024/11/18/nvidia-bionemo-framework-accelerates-ai-drug-discovery/

NVIDIA Invests in Genesis Therapeutics to Advance AI-Powered Drug Development

NVIDIA Invests in Genesis Therapeutics to Advance AI-Powered Drug Development

Genesis Therapeutics, a private biotech company based in London and focused on artificial intelligence, has secured funding from NVentures, NVIDIA’s (NVDA, Financial) corporate venture capital arm. However, the company remains undisclosed on… Article Source https://finance.yahoo.com/news/nvidia-invests-genesis-therapeutics-advance-145824964.html

Japan Develops Next-Generation Drug Design, Healthcare Robotics and Digital Health Platforms

Japan Develops Next-Generation Drug Design, Healthcare Robotics and Digital Health Platforms

To provide high-quality medical care to its population — around 30% of whom are 65 or older — Japan is pursuing sovereign AI initiatives supporting nearly every aspect of healthcare. AI tools trained on country-specific data and local… Article Source https://blogs.nvidia.com/blog/japan-sovereign-ai-healthcare/

Google DeepMind open-sources AlphaFold 3, ushering in a new era for drug discovery and molecular biology

Google DeepMind open-sources AlphaFold 3, ushering in a new era for drug discovery and molecular biology

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Google DeepMind has unexpectedly released the source code and model weights of AlphaFold 3 for academic use,… Article Source https://venturebeat.com/ai/google-deepmind-open-sources-alphafold-3-ushering-in-a-new-era-for-drug-discovery-and-molecular-biology/

[News] Indian Drug Company Aids Russia in Accessing NVIDIA Chips Amid Restrictions | TrendForce News

[News] Indian Drug Company Aids Russia in Accessing NVIDIA Chips Amid Restrictions | TrendForce News

According to a report from Bloomberg, a drug company in Mumbai, India, Shreya Life Sciences has engaged in trading chips of advanced technology to Russian, raising concerns among the… Article Source https://www.trendforce.com/news/2024/10/28/news-indian-drug-company-aids-russia-in-accessing-nvidia-chips-amid-restrictions/

Recursion and Google Cloud Announce Expansion of Partnership to Support Drug Discovery with Cloud and Exploration of Generative AI Technologies

Recursion and Google Cloud Announce Expansion of Partnership to Support Drug Discovery with Cloud and Exploration of Generative AI Technologies

SALT LAKE CITY and SUNNYVALE, Calif., Oct. 21, 2024 /PRNewswire/ — Recursion, a leading TechBio company decoding biology to radically improve lives, and Google Cloud today announced an expanded collaboration leveraging Google Cloud’s… Article Source https://www.prnewswire.com/news-releases/recursion-and-google-cloud-announce-expansion-of-partnership-to-support-drug-discovery-with-cloud-and-exploration-of-generative-ai-technologies-302281509.html

EVERSANA transforms pharmacovigilance & drug safety industry with Oracle collaboration, new global patient support model – PharmaLive

EVERSANA transforms pharmacovigilance & drug safety industry with Oracle collaboration, new global patient support model – PharmaLive

EVERSANA transforms pharmacovigilance & drug safety industry with Oracle collaboration, new global patient support model CHICAGO, IL (October 10, 2024) – EVERSANA, a leading provider of global commercialization services to the life sciences… Article Source https://www.pharmalive.com/eversana-transforms-pharmacovigilance-drug-safety-industry-with-oracle-collaboration-new-global-patient-support-model/

A Nobel for Google DeepMind is a tribute to how AI can transform drug discovery

A Nobel for Google DeepMind is a tribute to how AI can transform drug discovery

The Royal Swedish Academy of Sciences honoured University of Washington professor David Baker and two scientists from Google DeepMind, CEO Demis Hassabis and senior research scientist John Jumper. … Article Source https://www.livemint.com/opinion/online-views/google-deepmind-alphafold-ai-protein-structure-medicine-research-nobel-prize-for-chemistry-ai-drug-discovery-11728806211516.html